ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024
Identifying TRIM11 Upregulators as Therapeutic Targets in Alzheimer's Disease: A Bayesian Network Approach.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A recent study shows that TRIM11 is downregulated in Alzheimer's Disease (AD) but has been demonstrated to improve cognitive function when overexpressed in mouse AD models. Based on this discovery, our study aims to identify potential genetic regulators of TRIM11 using single-cell and single-nucleus RNA sequencing, and graph learning methods. In this study we explore two publicly available datasets: GSE173731 and GSE227222. To identify the potential regulators of TRIM11, we use a probabilistic approach and Bayesian networks. Our approach identified a set of candidate genes in both datasets that may exert regulatory influence on TRIM11, offering potential targets for further research in future therapeutic strategies in AD.
Indexed as
Identifiers
41726401PMC12919549What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.